Erlotinib D6 HCl
Erlotinib D6 HCl Basic information
- Product Name:
- Erlotinib D6 HCl
- Synonyms:
-
- Erlotinib D6
- Erlotinib Hydrochloride Impurity G
- [2H6]-Erlotinib Hydrochloride
- CP-358774 D6 hydrochloride
- NSC 718781 D6 hydrochloride
- OSI-774 D6 hydrochloride
- Erlotiniβ-d6 Hydrochloride
- D6-Erlotinib hydrochloride
- CAS:
- 1189953-78-3
- MF:
- C22H18ClD6N3O4
- MW:
- 435.933630668
- Mol File:
- 1189953-78-3.mol
Erlotinib D6 HCl Chemical Properties
- storage temp.
- Store at -20°C
- solubility
- DMSO: slightly, heated,Methanol: slightly soluble
- form
- A solid
- color
- White to off-white
Erlotinib D6 HCl Usage And Synthesis
Description
Erlotinib-d6 (hydrochloride) contains six deuterium atoms located on the methoxy group. It is intended for use as an internal standard for the quantification of erlotinib by GC- or LC-MS. Erlotinib is a tyrosine kinase inhibitor that acts on the epidermal growth factor receptor (EGFR), inhibiting EGFR-associated kinase activity (IC50 = 2.5 μM). This inhibits tumor growth in human head and neck carcinoma (HN5) tumor xenografts in mice with an ED50 value of 9 mg/kg. Erlotinib also suppresses cyclin-dependent kinase 2 (Cdk2) activity in breast cancer cells (IC50 = 4.6 μM) and JAK2 mutant JAK2V617F (IC50 = 5 μM), which is associated with polycythemia vera, idiopathic myelofibrosis, and essential thrombocythemia. Formulations containing erlotinib are used to treat certain forms of cancer, including non-small cell lung cancer.
Uses
Erlotinib D6 HCl is a Selective epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor, Antineoplastic.;Labeled Erlotinib, intended for use as an internal standard for the quantification of Erlotinib by GC- or LC-mass spectrometry.
References
[1] LUCA GIANNI Giacomo G. Targeting the epidermal growth factor receptor a new strategy in cancer treatment.[J]. I supplementi di Tumori?: official journal of Societa italiana di cancerologia ... [et al.], 2002, 1 4: S60-1.
[2] J D MOYER. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase.[J]. Cancer research, 1997, 57 21: 4838-4848.
[3] ROY S HERBST Paul A B. Targeting the epidermal growth factor receptor in non-small cell lung cancer.[J]. Clinical Cancer Research, 2003, 9 16 Pt 1: 5813-5824.
Erlotinib D6 HClSupplier
- Tel
- 021-50460086-9 15921403865
- han_yajun@dctc.daicel.com
- Tel
- 0755-0755-66853366 13670046396
- sales@chem-strong.com
- Tel
- 028-67271278 18628360895
- sales@artisbio.com
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
- Tel
- +1.415.685.4395
- enquiry@clearsynth.com
Erlotinib D6 HCl(1189953-78-3)Related Product Information
- Axitinib
- OSI-420
- 4-Methyl Erlotinib Hydrochloride
- 2,3,5-Trimethylpyridine-1-Oxide
- Didesmethyl Erlotinib Hydrochloride Salt
- Erlotinib iMpurity B
- Icotinib Impurity 1
- Erlotinib
- Erlotinib Impurity 93
- Icotinib Impurity 5
- 2-ETHYNYLANILINE 98
- Erlotinib
- Erlotinib Imp.9
- Erlotinib hydrochloride
- Erlotinib Hydrochloride iMpurity
- 4-ETHYNYLANILINE
- DesMethyl Erlotinib Carboxylate Acid
- 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline